|
End-of-day quote
NSE India S.E.
27/10/2026
|
5-day change | 1st Jan Change | ||
| 123.36 INR | -1.99% |
|
-12.36% | +76.23% |
Company Valuation: Valiant Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2024 | 2025 | 2026 |
|---|---|---|---|
| Market Cap 1 | 6,302 | 3,327 | 2,804 |
| Change | - | -47.2% | -15.74% |
| Enterprise Value (EV) 1 | 5,631 | 3,780 | 2,934 |
| Change | - | -32.87% | -22.38% |
| P/E | 1,725x | -150x | -79.4x |
| PBR | 2.66x | 1.42x | 0.9x |
| PEG | -17.4x | 0x | -2.9x |
| Capitalization / Revenue | 3.46x | 2.49x | 1.18x |
| EV / Revenue | 3.09x | 2.83x | 1.24x |
| EV / EBITDA | -65.5x | -77.6x | 43.2x |
| EV / EBIT | -54.3x | -55.8x | 303x |
| EV / FCF | -14.1x | -2.79x | -6.1x |
| FCF Yield | -7.11% | -35.9% | -16.4% |
| Dividend per Share 2 | - | - | - |
| Rate of return | - | - | - |
| EPS 2 | 0.0841 | -0.51 | -0.65 |
| Distribution rate | - | - | - |
| Net sales 1 | 1,821 | 1,334 | 2,375 |
| EBITDA 1 | -85.98 | -48.7 | 67.99 |
| EBIT 1 | -103.7 | -67.72 | 9.695 |
| Net income 1 | 3.196 | -22.01 | -32.68 |
| Net Debt 1 | -671.1 | 452.9 | 130.6 |
| Reference price 2 | 145.05 | 76.58 | 51.62 |
| Nbr of stocks (in thousands) | 43,450 | 43,450 | 54,313 |
| Announcement Date | 17/07/24 | 01/09/25 | 03/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 70.54M | ||
| 38.26x | 5.22x | 21.14x | 1.01% | 81.65B | ||
| 33.93x | 5.16x | 21.97x | 1.88% | 43.93B | ||
| 23.8x | 2.82x | 14.79x | 2.2% | 33.93B | ||
| 15.24x | 1.58x | 8.77x | 2.75% | 33.24B | ||
| 39.82x | 7.15x | 18.96x | 1.55% | 32.58B | ||
| 14.71x | 1.4x | 8.68x | 2.17% | 26.14B | ||
| 39.72x | 9.66x | 29.52x | 2.24% | 24B | ||
| 25.85x | 2.79x | 11.33x | 1.74% | 18.59B | ||
| 8.17x | 2.3x | 4.57x | 3.2% | 17.22B | ||
| Average | 26.61x | 4.23x | 15.53x | 2.08% | 31.14B | |
| Weighted average by Cap. | 29.51x | 4.48x | 17.11x | 1.86% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- VALIANTLAB Stock
- Valuation Valiant Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
















